BTAI
BioXcel Therapeutics, Inc.
Key Financials
Revenue
$642000
↓ 71.7%
Net Income
$-69897000
↓ 17.3%
Operating Income
$-50461000
↑ 25.0%
EPS (Diluted)
$-5.73
↑ 75.6%
Total Assets
$44.9M
↑ 17.2%
Total Liabilities
$140.4M
↑ 6.8%
Shareholders' Equity
$-95463000.00
↓ 2.5%
Cash & Equivalents
$28.4M
↓ 4.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BTAI |
| Company Name | BioXcel Therapeutics, Inc. |
| CIK | 1720893 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 203-643-8060 |